BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
World's top technology exhibition CES 2021
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

GC Pharma pledges unlimited free supply of immunoglobulin drug for plasma treatment

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : May 18, 2020, 10:44 | Updated : May 18, 2020, 10:44
  • 트위터
  • 페이스북
  • 웨이보

[Gettyimages Bank]

SEOUL -- GC Pharma, a biotech company in South Korea, pledged the unlimited free supply of an immunoglobulin drug based on plasma containing antibodies that neutralize a novel coronavirus, calling for the understanding of shareholders. The company is ready to carry out clinical trials for test production.

GC Pharma has been selected by the Korea Centers for Disease Control and Prevention (KCDC), a state health watchdog, as a preferred bidder for a research task to develop plasma treatment, which is different from plasma therapy involving the infusions of blood plasma from COVID-19 survivors to patients.

"There is no limit or any other preconditions on the quantity of free supply," GC Pharma said in a notice published on its website on Monday, promising to bear all expenses on the development of treatment and commercialization except for state funding.

The new drug called "GC5131A" should be used to stabilize public health, the company said, adding its decision is aimed at creating "a stable future rather than short-term profits."

South Korean drug and bio companies have jumped into the race to develop vaccines or treatments, while doctors have formed a task force to find proper treatment by mixing antiviral drugs including Remdesivir, a broad-spectrum antiviral medication developed by Gilead Sciences.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .S. Korea approves acquisition of COVID-19 vaccines for 60 % of entire population.
    S. Korea approves acquisition of COVID-19 vaccines for 60 % …
  • .Researchers detect antibodies 8 months after COVID-19 infection in asymptomatic or mildly symptomatic persons.
    Researchers detect antibodies 8 months after COVID-19 infect…
  • .Fusion research tokamak sets new record in super-hot plasma.
    Fusion research tokamak sets new record in super-hot plasma
  • .GC Pharmas immunoglobulin drug administered to patients in second-stage clinical study .
    GC Pharma's immunoglobulin drug administered to patients in …
  • .SK Bioscience embarks on clinical test of COVID-19 vaccine candidate NBP2001 .
    SK Bioscience embarks on clinical test of COVID-19 vaccine c…

Real Time Photo News

  • .Singer IU drops teaser image for upcoming full album.

    Singer IU drops teaser image for upcoming full album

  • .Cube Entertainment partners with web comics company to create online video content.

    Cube Entertainment partners with web comics company to create online video content

  • .Sci-fi film starring Song Joong-ki to be reelased on Netflix in February.

    Sci-fi film starring Song Joong-ki to be reelased on Netflix in February

  • .Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series Criminal Justice.

    Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series 'Criminal Justice'

  • .CJ ENM partners with NCSoft to roll out new digital content for global market.

    CJ ENM partners with NCSoft to roll out new digital content for global market

Latest News

more+

  • Singer IU drops teaser image for upcoming full album
  • Hyundai to complete construction of fuel cell production plant in China in 2022
  • Seoul builds solar power plant on idle land near urban expressway
  • Samsung showcases new Galaxy S21 smartphone models
  • Southern city launches joint research project to develop heavy-duty flying taxi drone
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view